Mus musculus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA247459 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:This work is part of the paper: Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model, Rothweiler S et al, Laboratory Investigation, 2014 (accepted) Hepatic Angiosarcoma (AS) is a rare and highly aggressive tumor of endothelial origin with dismal prognosis. Studies of the molecular biology of AS and treatment options are limited since animal models are rare. We have previously shown that inducible knockout of Notch1 in mice leads to spontaneous formation of hepatic AS. The aim of this study was to 1) establish and characterize a cell line derived from this murine AS, 2) to identify molecular pathways involved in the pathogenesis and potential therapeutic targets, and 3) to generate a tumor transplantation model. AS cells retained specific endothelial properties such as tube formation activity, as well as expression of CD31 and von Willebrand Factor. However, electron microscopy analysis revealed signs of dedifferentiation with loss of fenestrae and loss of contact inhibition. Microarray and pathway analysis showed substantial changes in gene expression and revealed activation of the Myc pathway. Exposing the AS cells to sorafenib reduced migration, filopodia dynamics, and cell proliferation but did not induce apoptosis. In addition, sorafenib suppressed ERK phosphorylation and expression of cyclin D2. Injection of AS cells into NOD/SCID mice resulted in formation of undifferentiated tumors confirming the tumorigenic potential of these cells. Conclusion: We established and characterized a murine model of spontaneous AS formation and hepatic AS cell lines as a useful in vitro tool. Our data demonstrate antitumor activity of sorafenib in AS cells with potent inhibition of migration, filopodia formation, and cell proliferation, which support further evaluation of sorafenib as a novel treatment strategy. In addition, AS cell transplantation provides a subcutaneous tumor model useful for in vivo preclinical drug testing. Mouse liver samples (Notch1 knockout and wild type control, 3 animals per group) and angiosarcoma cell lines (3 independently derived lines) were analyzed.
2014-09-30 | E-GEOD-57655 | biostudies-arrayexpress
Project description:Transcription profiling of midbrain samples from Ezh2 knockout mouse embryos
2016-01-08 | E-GEOD-74538 | ExpressionAtlas
Project description:Transcription profiling by array of Pten knockout liver cells of mouse
2016-04-22 | E-GEOD-70681 | ExpressionAtlas
Project description:Expression data from macroH2A1/2 double knockout fetal mouse liver
2014-10-28 | E-GEOD-57086 | ExpressionAtlas
Project description:RNA-Seq analysis of KLF3 knockout E14.5 TER119+ (erythroid) murine fetal liver cells
2019-05-14 | E-GEOD-50554 | ExpressionAtlas
Project description:Transcriptome profiling of liver samples of C/EBP uORF mice
2019-01-16 | E-MTAB-6435 | ExpressionAtlas
Project description:This work is part of the paper: Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model, Rothweiler S et al, Laboratory Investigation, 2014 Hepatic Angiosarcoma (AS) is a rare and highly aggressive tumor of endothelial origin with dismal prognosis. Studies of the molecular biology of AS and treatment options are limited since animal models are rare. We have previously shown that inducible knockout of Notch1 in mice leads to spontaneous formation of hepatic AS. The aim of this study was to 1) establish and characterize a cell line derived from this murine AS, 2) to identify molecular pathways involved in the pathogenesis and potential therapeutic targets, and 3) to generate a tumor transplantation model. AS cells retained specific endothelial properties such as tube formation activity, as well as expression of CD31 and von Willebrand Factor. However, electron microscopy analysis revealed signs of dedifferentiation with loss of fenestrae and loss of contact inhibition. Microarray and pathway analysis showed substantial changes in gene expression and revealed activation of the Myc pathway. Exposing the AS cells to sorafenib reduced migration, filopodia dynamics, and cell proliferation but did not induce apoptosis. In addition, sorafenib suppressed ERK phosphorylation and expression of cyclin D2. Injection of AS cells into NOD/SCID mice resulted in formation of undifferentiated tumors confirming the tumorigenic potential of these cells. Conclusion: We established and characterized a murine model of spontaneous AS formation and hepatic AS cell lines as a useful in vitro tool. Our data demonstrate antitumor activity of sorafenib in AS cells with potent inhibition of migration, filopodia formation, and cell proliferation, which support further evaluation of sorafenib as a novel treatment strategy. In addition, AS cell transplantation provides a subcutaneous tumor model useful for in vivo preclinical drug testing.
2014-09-30 | GSE57655 | GEO
Project description:Transcription profiling of 3 mouse cell lines infected with Leishmania
2015-10-22 | E-MEXP-2554 | ExpressionAtlas
Project description:Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples
2025-01-24 | E-GEOD-74000 | ExpressionAtlas
Project description:Transcription profiling by array of mouse vaginal samples following adjuvant treatment
2015-09-17 | E-GEOD-27149 | ExpressionAtlas